Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Type 1 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America
- 1st Edition, Volume 53-1 - January 29, 2024
- Editor: Osagie Ebekozien
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 2 8 9 9 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 2 9 0 0 - 1
In this issue of Endocrinology and Metabolism Clinics of North America, guest editor Dr. Osagie Ebekozien brings his considerable expertise to the topic of Type 1 Diabetes.… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Endocrinology and Metabolism Clinics of North America, guest editor Dr. Osagie Ebekozien brings his considerable expertise to the topic of Type 1 Diabetes. Top experts in the field provide a timely update on type 1 diabetes care in children and adults, and provide recommendations for treatment and improving access to care.
- Contains 14 relevant, practice-oriented topics including type 1 diabetes population health improvement; access to care for type 1 diabetes; emerging technologies and therapeutics; social determinants of health (SDOH) in type 1 diabetes; COVID-19 and type 1 diabetes; and more.
- Provides in-depth clinical reviews on type 1 diabetes, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Endocrinologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Foreword
- Preface
- Improving Outcomes for People with Type 1 Diabetes Through Collaboration: Summary of Type 1 Diabetes Exchange Quality Improvement Collaborative Studies
- Key points
- Introduction
- Population health research insights from Type 1 diabetes exchange quality improvement collaborative
- Discussion
- Clinics care points
- Disclosure
- Funding statement
- Type 1 Diabetes Screening and Diagnosis
- Key points
- Who to evaluate for type 1 diabetes
- Screening programs
- Ways to screen asymptomatic participants
- Disease staging and risk of progression
- Risk calculations and type 1 diabetes risk scores
- Current diagnostic tools used in making the diagnosis of stage 3 type 1 diabetes
- Clinical implications and recommendations
- Clinics care points
- Optimizing Glycemic Outcomes for Children with Type 1 Diabetes
- Key points
- Introduction
- Defining glycemic outcomes
- Approach to optimizing glycemic outcomes: diabetes education
- Approach to optimizing glycemic outcomes: nutrition and physical activity
- Approach to optimizing glycemic outcomes: diabetes technology
- Approach to optimizing glycemic outcomes: psychosocial needs
- Summary
- Clinics care points
- Young Adults with Type 1 Diabetes
- Key points
- Introduction
- Section one: Unique health-care considerations for young adults with type 1 diabetes
- Section two: Evidence-based strategies to improve outcomes for young adults with type 1 diabetes
- Section three: Summary and future directions
- Clinics care points
- Incorporating the Six Core Elements of Health Care Transition in Type 1 Diabetes Care for Emerging Adults
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes
- Key points
- Introduction
- Background
- Approach
- Future research considerations
- Discussion
- Summary
- Clinics care points – Bulleted list of evidence-based pearls and pitfalls relevant to the point of care
- Case study
- Disclosure
- Emerging Technologies and Therapeutics for Type 1 Diabetes
- Key points
- Introduction
- Continuous glucose monitoring systems
- Hybrid closed loops
- Smart insulin pens, pen caps
- Disparities in the use of diabetes technology in type 1 diabetes
- Inpatient use of continue glucose monitoring
- Stem cell therapies
- Adjunctive therapies in type 1 diabetes
- Summary
- Clinics care points
- Disclosures
- Social Determinants of Health Screening in Type 1 Diabetes Management
- Key points
- Introduction
- Definitions
- Historical perspectives
- Impact of social determinants of health: Cost burden
- Social determinants of health screening: Implementation
- Readiness tool kit
- Summary
- Clinics care points
- Psychosocial Care for Youth with Type 1 Diabetes: Summary of Reviews to Inform Clinical Practice
- Key points
- Introduction
- Youth-focused behavioral health interventions
- Family-based behavioral health interventions
- Health equity interventions
- Discussion
- Clinics care points
- Acute and Chronic Adverse Outcomes of Type 1 Diabetes
- Key points
- Introduction
- Acute complications
- Chronic complications
- Summary
- Clinics care points
- Type 1 and Covid-19: Diagnosis, Clinical Care, and Health Outcomes during the Pandemic
- Key points
- Background
- Discussion
- Summary
- Clinics care points
- Type 1 Diabetes and Cardiovascular Health
- Key points
- Introduction
- Epidemiology of cardiovascular disease in type 1 diabetes
- Risk factors for cardiovascular disease in type 1 diabetes
- Prediction of cardiovascular disease in type 1 diabetes
- Cardiovascular disease prevention in type 1 diabetes
- Cardiovascular health in type 1 diabetes
- Considerations
- Summary
- Clinics care points
- Stakeholder Engagement in Type 1 Diabetes Research, Quality Improvement, and Clinical Care
- Key points
- Introduction
- Fundamentals and framework of stakeholder engagement
- Stakeholder engagement in research
- Stakeholder engagement in diabetes research
- Stakeholder engagement in diabetes and diversity
- Stakeholder engagement in quality improvement of diabetes care
- Stakeholder engagement in diabetes clinical care
- Summary
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 53-1
- Published: January 29, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443128998
- eBook ISBN: 9780443129001
OE
Osagie Ebekozien
Affiliations and expertise
Vice President of Population Health and Quality, Improvement at the T1D Exchange